Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 17 March 2022, 18:00 HKT/SGT
Share:
    

Source: BBGI PCL
BBGI PCL (SET: BBGI) Debuts Shares on the SET March 17
Aiming to be a leading bio-product group with green innovation and sustainability

BANGKOK, Mar 17, 2022 - (ACN Newswire) - BBGI PCL (SET: BBGI), a leader in the biofuel energy industry and creator of health-promoting high-value bio-products (HVP) for health and well-being, debuted its shares on the Stock Exchange of Thailand today under the symbol BBGI. Executives and financial advisers are confident investors will respond enthusiastically due to the company's strong foundation as a market leader in bio-fuels and the HVP industry in ASEAN.

Mr. Kittiphong Limsuwannarot, Chief Executive Officer and President of BBGI, introduced shares on the SET for trading on March 17, 2022, under the symbol "BBGI". He expressed confidence in the company's business potential, based on its strong foundation as a leading producer and distributor of biofuels in Thailand with a 17-year experience, and major shareholders KSL and BCP, upstream and downstream business operators for ethanol and biodiesel products, supporting BBGI's flagship biofuels business, and providing synthetic biology (SynBio) technology for the manufacture of HVP products to meet consumer trends in Health and Well-being in ASEAN.

M.L. Thongmakut Thongyai, Chief Executive Officer of Krungthai Zmico Securities Co., Ltd., as financial adviser and lead underwriter, says BBGI has a solid expertise in biotechnology derived from an integrated biofuels operation dealing with both ethanol and biodiesel. Advanced production technologies are used to enhance cost management efficiency and spur growth, he says. The company builds on its expertise in a way that helps it become a leading operator of High Value Bio-products (HVP) in Health and Well-being, which is a high-growth market with good gross profit rates. As such BBGI can be considered a company with strong business potential and opportunity for growth, and its shares will doubtless be appreciated by investors.

Corporate Communications Department
BBGI Public Company Limited
Tel: +66 2335 8826
Email: corp.comm@bbgigroup.com
Visit BBGI PCL at https://www.bbgigroup.com/en

BBGI PCL Equity [SET: BBGI] [RIC: BBGI:BK] [BB: BBGI:TB]
Released for BBGI PCL by MT Multimedia Co Ltd
Yuttachai Paikonahok (Tle), T: +66 91 736 2866; E: yuttachai.p@mtmultimedia.com


Topic: Press release summary
Source: BBGI PCL

Sectors: Daily Finance, BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten  
Dec 12, 2025 14:35 HKT/SGT
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition  
Friday, December 12, 2025 10:00:00 AM
2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion  
Dec 11, 2025 22:15 HKT/SGT
CMS (867/8A8): NDA of Innovative Drug Y-3 for Injection for Acute Ischemic Stroke Accepted in China  
Dec 11, 2025 20:00 HKT/SGT
Focus Graphite Achieves 99.9996 wt.% Ultra-High Purity and 2.03 ppm EBC in Follow-On Testing  
Dec 11, 2025 18:09 HKT/SGT
Nasdaq Verafin Joins Global Anti-Scam Alliance  
Dec 11, 2025 14:21 HKT/SGT
Dr. Teck Lim Chia, Chairman and CEO of CBL International, Honored at the Prestigious Directors of the Year Awards  
Dec 11, 2025 12:54 HKT/SGT
Cloudbreak Pharma Soars 80%+ on Multiple Catalysts, Driving Value Re-Rating  
Dec 11, 2025 08:20 HKT/SGT
Indonesian Government's Swift Response in Recovering Flood-hit Sumatra  
Dec 10, 2025 23:30 HKT/SGT
TIS Helps Treasury Teams Navigate the Ongoing ISO 20022 Transition After the 2025 Banking Deadline  
Dec 10, 2025 21:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: